# Relmada Therapeutics, Inc.: Form 8-K, filed Sep 22, 2022

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2022-09-22
- Accepted by EDGAR: Sep 22, 2022, 17:19 ET
- Period: 2022-09-21
- Accession: 0001213900-22-058066
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390022058066/ea166170-8k_relmadather.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390022058066/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390022058066/ea166170-8k_relmadather.htm

Filed Sep 22, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-058066. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
